Competition between CTL narrows the immune response induced by prime-boost vaccination protocols.
Recombinant vaccines encoding strings of virus- or tumor-derived peptides and/or proteins are currently being designed for use against both cancer and infectious diseases. These vaccines aim to induce cytotoxic immune responses against several Ags simultaneously. We developed a novel tetramer-based...
Príomhchruthaitheoirí: | Palmowski, M, Choi, E, Hermans, I, Gilbert, S, Chen, J, Gileadi, U, Salio, M, Van Pel, A, Man, S, Bonin, E, Liljestrom, P, Dunbar, P, Cerundolo, V |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2002
|
Míreanna comhchosúla
Míreanna comhchosúla
-
The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.
de réir: Hermans, I, et al.
Foilsithe / Cruthaithe: (2004) -
High avidity antigen-specific CTL identified by CD8-independent tetramer staining.
de réir: Choi, E, et al.
Foilsithe / Cruthaithe: (2003) -
CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens.
de réir: Salio, M, et al.
Foilsithe / Cruthaithe: (2004) -
Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response.
de réir: Palmowski, M, et al.
Foilsithe / Cruthaithe: (2004) -
Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
de réir: Smith, C, et al.
Foilsithe / Cruthaithe: (2005)